Skip to main content

Table 2 Pharmacokinetic analyses of individual markers a

From: Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds

 

Sinistrin

PAH

( S )-pindolol

( R )-pindolol

Fluconazole

 

( n =15)

( n =19)

( n =14)

( n =14)

( n =18)

AUC0-∞, mcg/ml/min, mean (95% CI)

16,513 (12,247 to 20,778)

426 (366 to 487)

8.70 (3.07 to 14.3)

11.2 (1.42 to 21.0)

3,804 (3,073 to 4,535)

CL, ml/min, mean (95% CI)

180 (141 to 219)

1,139 (943 to 1,335)

654 (465 to 842)

639 (393 to 884)

30.5 (24.4 to 36.6)

Ae, mg, mean (95% CI)

–

230 (211 to 249)

0.80 (0.36 to 1.24)

0.77 (0.39 to 1.15)

35.9 (27.4 to 44.3)

CLR, ml/min, mean (95% CI)

–

594 (484 to 704)

122 (77 to 167)

98 (68 to 129)

12.3 (7.61 to 16.9)

CLNR, ml/min, mean (95% CI)

–

545 (439 to 652)

532 (369 to 695)

541 (310 to 772)

18.2 (15.5 to 21.0)

CLNR, mean (95% CI)

–

47.8 (43.5 to 52.0)

80.9 (75.8 to 86.0)

81.5 (76.3 to 86.8)

64.1 (55.7 to 72.6)

CLCR, ml/min, mean (95% CI)

156 (125 to 188)

164 (135 to 193)

166 (127 to 204)

166 (127 to 204)

171 (140 to 203)

  1. aAe, Amount recovered in urine; AUC0-∞; Area under the concentration/time curve (extrapolated to infinity); CI, Confidence interval; CL, Clearance; CLCR, Creatinine clearance; CLNR, Non-renal clearance; CLR, Renal clearance; PAH, p-Aminohippuric acid.